Bacillus alcalophilus peptidoglycan induces IFN-alpha-mediated inhibition of vaccinia virus replication

FEMS Immunology and Medical Microbiology
Ge LiuKen Alibek

Abstract

Bacterial products such as cell walls (CW) and peptidoglycan (PGN) are known to activate macrophages and NK cells during microbial infections. In this report, we demonstrated that whole CW and PGN of four Gram-positive bacteria are capable of enhancing the anti-poxviral activity of murine macrophage RAW 264.7 cells. Among the major Bacillus alcalophilus CW components, PGN contributes the most to antiviral activity and induces remarkably higher levels of IFN-alpha. Anti-IFN-alpha/beta antibody, but not anti-IFN-gamma, anti-IFN-gamma receptor, or anti-IL-12, reversed the PGN-induced inhibition of vaccinia virus replication and reduced nitric oxide (NO) production. Our data thus suggest that PGN induce antiviral activity through IFN-alpha and to a lesser extent, through NO production.

References

Feb 1, 1989·Scandinavian Journal of Immunology·R Barot-CiorbaruC Carnaud
Apr 1, 1989·Journal of Leukocyte Biology·P A LeBlanc
Jan 1, 1989·International Journal of Immunopharmacology·K N MasihiL Chedid
Aug 1, 1985·Journal of Leukocyte Biology·F KellerA Kirn
Jan 1, 1985·British Medical Bulletin·P S MorahanK R Leary
Jul 1, 1972·The Journal of Clinical Investigation·N S YoungR A Prendergast
Sep 1, 1994·Immunity·J PuginR J Ulevitch
Sep 14, 1994·Journal of Immunological Methods·F Keller
May 1, 1994·The Journal of Experimental Medicine·P Di MarzioS Gessani
Nov 1, 1993·International Immunology·M J FultzS N Vogel
Dec 1, 1995·Immunological Reviews·M F van den BroekM Aguet
May 1, 1997·Biochemical Society Transactions·C A Biron
Jun 10, 1998·Cytokine & Growth Factor Reviews·J Vilcek
Mar 6, 1999·Microbiology and Molecular Biology Reviews : MMBR·W W Navarre, O Schneewind
Jul 7, 1999·Neuroimmunomodulation·M J PabstJ M Krueger
Apr 25, 2000·International Journal of Antimicrobial Agents·K N Masihi
May 2, 2000·Applied and Environmental Microbiology·C SignorettoP Canepari
Jan 4, 2001·International Journal of Immunopharmacology·K N Masihi
Mar 13, 2001·Annual Review of Immunology·L G Guidotti, F V Chisari
Sep 5, 2002·Nature Reviews. Immunology·Michael G KatzeMichael Gale
Feb 12, 2008·Current Protocols in Molecular Biology·P L EarlM W Carroll

❮ Previous
Next ❯

Citations

Oct 5, 2016·Biochemical Pharmacology·T G VillaJ M Ageitos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.